Nisa Investment Advisors
WHWK

Nisa Investment Advisors’s Whitehawk Therapeutics WHWK Stock Holding History

Nisa Investment Advisors’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-131
Closed -$191 – 3061
2024
Q2 		$191 Buy
131
+121
+1,210% +$224 ﹤0.01% 2820
2024
Q1 		$23 Buy
+10
New +$19 ﹤0.01% 2777
2023
Q4 		– Sell
-1,391
Closed -$6.73K – 2767
2023
Q3 		$6.73K Buy
+1,391
New +$8.09K ﹤0.01% 2245
2023
Q1 		– Sell
-5
Closed – – 2747
2022
Q4 		$0 Buy
+5
New +$65 ﹤0.01% 2754

Other funds holding WHWK

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AI
Acuitas Investments Seattle, Washington $1.41M AUM 48.57% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Nisa Investment Advisors's WHWK Position: Q3 2024 in Review

Nisa Investment Advisors sold out of Whitehawk Therapeutics (WHWK) in Q3 2024, closing a stake of 131 shares — an estimated $191 sold.

Nisa Investment Advisors first reported a position in WHWK in Q4 2022 and held it in 4 quarters. The position peaked at $6.73K in Q3 2023. 52 funds tracked by Wall St. Rank hold WHWK as of Q3 2024.

  • Nisa Investment Advisors reported no remaining Whitehawk Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Nisa Investment Advisors sold 131 Whitehawk Therapeutics shares in Q3 2024, an estimated $191.
  • Nisa Investment Advisors first reported a position in Whitehawk Therapeutics in Q4 2022 and held it in 4 quarters.
  • Nisa Investment Advisors's Whitehawk Therapeutics position peaked at $6.73K in Q3 2023.
  • 52 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q3 2024.

Based on Nisa Investment Advisors's 13F filing for Q3 2024, filed 24 Oct 2024.